Desk›Healthcare› Godavari Drugs Ltd
Godavari Drugs Ltd
BSE 530317 · NSE GODAVARI · ISIN INE362C01012 · Group XT · Active
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
₹98.00
-2.00%
BSE close, 28 August 2026
₹99.25 cr
1.0 cr shares · Micro cap
₹47.03 cr
as published
23.8× · 2.38×
EPS ₹4.11 · BV ₹41.18
105.81 / 4.09
₹ cr, as filed
16
2 selected · 12%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -27.5% |
|---|---|
| Against 52-week low | +40.6% |
| Day change | -2.00% |
| Size band | Micro cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹4.11 |
|---|---|
| Price / earnings | 23.84× |
| Price / book | 2.38× |
| Book value — derived, price ÷ P/B | ₹41.18 |
| Return on equity | 9.98% |
| Operating margin | 9.54% |
| Net margin | 3.97% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 9.98%
- ROE as published
- 9.98%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 27.96 | 1.11 | 1.10 | 9.54% | 3.97% |
| Mar-26 · Q | 33.16 | 1.29 | 1.71 | 9.61% | 3.89% |
| FY25-26 | 105.81 | 4.09 | 5.43 | 10.85% | 3.86% |
Quarter on quarter
- Revenue, quarter on quarter
- -15.7%
- Net profit, quarter on quarter
- -14.0%
- Operating margin, quarter on quarter
- -7 bps
Disclosure profile 16 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Board Outcome | 1 |
| Results | 1 |
| Selected sub-total | 2 |
| Procedural | |
| AGM / EGM | 2 |
| Board Meeting | 2 |
| Newspaper Publication | 2 |
| Allotment | 1 |
| Annual Report | 1 |
| Book Closure | 1 |
| Charter Amendment | 1 |
| General | 1 |
| Other Update | 1 |
| Outcome | 1 |
| Trading Window | 1 |
| Procedural sub-total | 14 |
| Total | 16 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group XT, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
16 filings · 2 selected · busiest 2026-09-01
Filing rhythm · the twelve most recent
2026-08-142026-09-25
SelectedProcedural
Filings
16 in the window · 1 earlier on record
-
25 September 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of the 38th AGM held on 25.09.2026
AGM/EGM / AGM View filing →
-
21 September 2026 ·
Closure of Trading Window
Intimation of Closure of Trading Window with effect from 1st October, 2026, for the purpose of consideration and approval of the unaudited Financials for the quarter and half year ended ....
Insider Trading / SAST / Closure of Trading Window View filing →
-
3 September 2026 ·
Intimation Of Dispatch Of Physical Letters Pursuant To Regulation 36(1)(B) Of The SEBI (LODR) Regulations
We hereby inform that the company has dispatched a physical letter to the shareholders whose email addresses are not registered with the company/RTA/Depositories/DP. The Letter contains ....
Company Update / General View filing →
-
3 September 2026 ·
Newspaper Publication
Newspaper Publication for the 38th Annual General Meeting and E-Voting Instructions
Company Update / Newspaper Publication View filing →
-
1 September 2026 ·
Reg. 34 (1) Annual Report.
The Company informed that the 38th AGM of the Company is scheduled to be held on Friday, the 25th Sep 2026 at 03.00 pm through Video Conferencing/ other Audio Visual means in accordance ....
Others / Reg. 34 (1) Annual Report View filing →
-
1 September 2026 ·
39Th AGM To Be Held On 25Th Sep 2026 At 11.00 A.M. Through Video Conferencing
Notice of 38th AGM to be held on 25th Sep 2026 at 03.00 p.m. through Video Conferencing/Other Audio Visual Means in accordance with the relevant circulars issued by the MCA and SEBI.
AGM/EGM / AGM View filing →
-
1 September 2026 ·
38Th AGM To Be Held On 25.09.2026 - Book Closure - 19.09.2026 - 25.09.2026 (Both Days) And Evoting, Cutoff Date.
The Register of Members and Share Transfer Books of the Company will remain closed from 19.09.2026 to 25.09.2026 (Both days Inc lusive) for taking record of the Members of the Company for ....
Corp. Action / Book Closure View filing →
-
1 September 2026 ·
Amendments to Memorandum & Articles of Association
Amendment to MOA of the company was approved by Board of Directors. The Proposed change in MOA of the company is subject to necessary approvals from Ministry of Corporate Affairs, Shareholders ....
Company Update / Amendments to Memorandum & Articles of Association View filing →
-
31 August 2026 ·
Board Meeting Outcome for Outcome Of Board Meeting Held On 31.08.2026 - Alteration Of The Main Objects Clause III(A) Of The Memorandum Of Association And Approval Of Revised Notice Of The 38Th Annual General Meeting
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we inform that the Board of Directors at its meeting held on 31st August, 2026 approved the following: 1. Alteration of the ....
Others / Outcome without intimation View filing →
-
17 August 2026 ·
Submission Of Statement On Deviation Or Variation In Utilisation Of Funds For The Quarter Ended 30 June 2026
Submission of Statement on Deviation or Variation in uitilisation of Funds for the quarter ended 30 june 2026
Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation View filing →
-
17 August 2026 ·
Newspaper Publication
Newspaper Publication of Unaudited Results for quarter ended 30.06.2026
Company Update / Newspaper Publication View filing →
-
14 August 2026 ·
Allotment
Board of Directors of the Company in its meeting held on Friday, 14th August, 2026 at 11.45 A.M. approved and passed the resolution for allotment of Equity Shares on conversion of 7,86,690 ....
Company Update / Allotment of Equity Shares View filing →
-
14 August 2026 ·
Submission Of Un-Audited Standalone Financial Results For The Quarter Ended As On June 30, 2026
Submission of Un-Audited Standalone Financial Results for the Quarter ended as on June 30, 2026
Result / Financial Results View filing →
-
14 August 2026 ·
Board Meeting Outcome for Outcome Of Board Meeting Held On 14.08.2026
Submission of Un-Audited Standalone Financial Results for the Quarter ended as on June 30, 2026 and Allotment of Equity Shares on conversion of 7,86,690 (Seven Lakhs Eighty-Six Thousand ....
Board Meeting / Outcome of Board Meeting View filing →
-
11 August 2026 ·
Update on board meeting
Godavari Drugs Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Update on board meeting - Intimation ....
Board Meeting / Board Meeting View filing →
-
10 August 2026 ·
Board Meeting Intimation for Considering And Approving The Un-Audited Financial Results Of The Company For The Quarter Ended June 30, 2026.
Godavari Drugs Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve the Un-audited Financial Results ....
Board Meeting / Board Meeting View filing →
RSS feed for Godavari Drugs Ltd · the 50 most recent filings